Kembali
KLBF - Kalbe Farma

KLBF – 9M25 net profit up 10.6% yoy; eyes higher dividend ratio

28 November 2025

KLBF – 9M25 net profit up 10.6% yoy; eyes higher dividend ratio Kalbe Farma (KLBF) reported a net profit of IDR2.63 tn in 9M25 (+10.63% yoy), supported by a 7.21% yoy revenue increase to IDR25.98 tn. Growth was driven by strong performance in the prescription (+11% yoy), consumer health (+9.4% yoy), and distribution & packaging (+10.3% yoy) segments. Supported by healthy operating cash flow, management hinted at potentially increasing the dividend payout ratio to 50%-60% of net profit. The company remains focused on fundamental growth and innovation despite its recent reclassification to the MSCI Indonesia Small-Cap Index. (Source : Kontan)

Related Research

Healthcare
KLBF - Further growth in ‘25F on better product mix and costs ma...
Andre Suntono 13 Juni 2025 Lihat Detail
Consumer
KLBF - Terus bertumbuh di kuartal II/2022
Winny Rahardja 05 Agustus 2022 Lihat Detail
Consumer
KLBF - Perbaikan ekonomi topang performa bisnis di masa depan
Winny Rahardja 08 April 2022 Lihat Detail